Nutritional Status and Its Modifications After Hip Replacement
Prognostic Potential of the Preoperative Nutritional Status and Its Postoperative Variation in Patients Undergoing Hip Arthroplasty
2 other identifiers
observational
60
1 country
1
Brief Summary
Data literature lacks of evidence concerning the variation of the nutritional status in patients undergoing hip surgery, thus preventing an effective application a nutritional support program. It is therefore necessary to start identifying the clinical steps (pre-operative and post-operative) that may be defined as critical control points for malnutrition. The observation should foresee the identification of nutritional status indicators, such as weight, hemoglobin, albumin, food intake, and others that might affect a proper recovery. This study aims to investigate the prognostic nutritional factors that might influence clinical outcomes, and their variation in relation to hospitalization and rehabilitation periods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2019
CompletedStudy Start
First participant enrolled
May 31, 2019
CompletedFirst Posted
Study publicly available on registry
June 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedMay 11, 2023
May 1, 2023
3 years
May 22, 2019
May 9, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline level of hemoglobin at 14 days after surgical operation
One of the main decision-making factors that guide the clinician to discharge the patient is the hemoglobin level. The association between preoperative hemoglobin and hemoglobin at discharge was already observed in past orthopedic cohorts, with a loss of 3.3 g/dl being considered clinically relevant. Patients with a better nutritional status may have a reduced fall in hemoglobin after the surgical operation.
Before the surgical operation, after 3 days, after 14 days.
Secondary Outcomes (11)
Change from baseline level of pre-albumin at 14 days after surgical operation
Before the surgical operation, after 3 days, after 14 days.
Change from baseline level of total lymphocyte count at 14 days after surgical operation
Before the surgical operation, after 3 days, after 14 days.
Change from baseline level of iron at 14 days after surgical operation
Before the surgical operation, after 3 days, after 14 days.
Change from baseline level of vitamin D at 14 days after surgical operation
Before the surgical operation, after 3 days, after 14 days.
Change from baseline of weight 14 days after surgical operation
Before the surgical operation, after 3 days, after 14 days.
- +6 more secondary outcomes
Eligibility Criteria
Primary care clinic
You may qualify if:
- caucasian
- arthroplasty intervention program with hip prosthesis placement
- signature and acceptance of informed consent to collaborate in all the procedures necessary for the study
You may not qualify if:
- heart failure stage III-IV
- renal failure stage III-IV
- actual cancer
- past neurological disorders (including, but not limited to cerebral ischemia, cerebral haemorrhages, brain tumors, endocranial aneurysms)
- neurodegenerative disorders (including, but not limited to Alzheimer's dementia, fronto-temporal dementia)
- actual major psychopharmacological therapies
- pregnancy certified by self-declaration
- inability to adhere to the rehabilitation protocol or to carry out the controls
- non-acceptance of informed consent
- revision interventions
- previously established and documented sleep disorders
- shift or part-time worker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Istituto Ortopedico Galeazzi
Milan, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matteo Briguglio
IRCCS Istituto Ortopedico Galeazzi
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2019
First Posted
June 10, 2019
Study Start
May 31, 2019
Primary Completion
June 1, 2022
Study Completion
June 1, 2022
Last Updated
May 11, 2023
Record last verified: 2023-05